| Sep 13, 2011
| 8:24 AM
LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
| Aug 10, 2012
Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle.
Such a person would have "maybe some stomach problem, but not die," he told...
| Sep 4, 2012
| 4:05 PM
LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday.
In new advice about...
| Sep 5, 2012
| 12:45 PM
Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline.
Human Genome, which employs about 1,000 people in Rockville, could...
| Oct 17, 2012
| 3:19 PM
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
| Jun 8, 2012
| 1:54 PM
Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion.
Ripley Entertainment Inc. said exhibits at the Inner Harbor...
| Jul 2, 2012
| 10:35 AM
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
| Jul 16, 2012
| 4:00 PM
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...
| Jul 16, 2012
| 8:54 PM
For years people around the country have been climbing mountains for CureDuchenne.
As they raise money and awareness, they also get younger.
Most recently, 8-year-old Tyler Armstrong climbed Mt. Kilimanjaro and helped raise about $40,000 for the Newport...
| Jul 18, 2012
| 11:43 AM
LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.
The United Nations...
| May 6, 2011
Lupus is a challenging disease that often leaves patients feeling alone and misunderstood. While many patients might not “look” sick, they may be silently managing the debilitating pain, fatigue and other symptoms associated with lupus. This...